The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial introduction generated massive profits, the expiration of its exclusive rights opened the door to off-brand alternatives, dramatically eroding market share. This poses a specific dilemma for firms banking on related blockbuster products, sugge

The history of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in income, its intellectual property lapse created a flood of knock-off medications, significantly diminishing its position . While specific firms may seek get more info to capitalize on male sex